Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)

TPEX:6704 Revenue

Gwo Xi Stem Cell Applied Technology Co. , had revenue of 65.33M TWD in the half year ending June 30, 2026, a decrease of -17.94%. This brings the company's total for the last twelve months to 157.86M, down -14.63% year-over-year. In the year 2025, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 187.02M with 10.00% growth. That makes Gwo Xi Stem Cell Applied Technology Co. , the 40,071st largest company in the world by revenue and 2,072nd in Taiwan.

• Revenue (ttm): 157.86M
• Revenue Growth: -14.63%
• P/S Ratio: 12.10
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.91B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Health product income 70.25M 37.6%
• Cell services income 44.98M 24.0%
• Revenue From Cell Foundry 44.29M 23.7%
• Income from inspection of cell quality 27.52M 14.7%

Fiscal year ended Dec 31, 2025 See the full TPEX:6704 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	187.02M	17.00M	10.00%
Dec 31, 2024	170.03M	28.85M	20.44%
Dec 31, 2023	141.18M	-39.49M	-21.86%
Dec 31, 2022	180.67M	-62.09M	-25.58%
Dec 31, 2021	242.75M	54.21M	28.75%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 28, 2026

Data Sources Report a data error